Form 4: Predictive Oncology Director Charles Lee Nuzum Sr. Reports Acquisition of Common Stock

Director Charles Lee Nuzum Sr. reports acquiring 3,268 shares of Predictive Oncology Inc. common stock on April 5, 2024.

Summary

• On April 5, 2024, Charles Lee Nuzum Sr., a director of Predictive Oncology Inc., acquired 3,268 shares of common stock.
• The transaction resulted in Mr. Nuzum beneficially owning 31,921 shares following the reported transaction.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock acquisition by a director. The acquisition itself could be seen as mildly positive, but the filing is simply a procedural requirement.

Positives

• A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of shares by a director may positively influence shareholder sentiment.

Key Dates

Keywords

Predictive Oncology Inc., Director, Stock Acquisition, Beneficial Ownership, Form 4, POAI, Nuzum